NATIONAL TUBERCULOSIS ELIMINATION PROGRAMME: PART 1

1234
Across
  1. 3. A TB patient, who is resistant to Isoniazid (H) only
  2. 4. Preferred investigation of choice in Diagnosis of Pediatric TB
Down
  1. 1. Developed by ICMR,this is an Indian version of CB-NAAT
  2. 2. Any MDR patient (H+R) resistant to any fluoroquinolone and Group-A drugs (Bedaquiline, Linezolid, Levo/Moxifloxacin)